# FDA Inspection 1276175 - Shenzhen Hepalink Pharmaceutical Group Co., Ltd. - June 13, 2025

Source: https://www.keypedia.com/records/fda_inspections/shenzhen-hepalink-pharmaceutical-group-co-ltd/d2e06d09-e936-429d-9dc1-990d727e77f8
Source feed: FDA_Inspections

> FDA Inspection 1276175 for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on June 13, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1276175
- Company Name: Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
- Inspection Date: 2025-06-13
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1276175 - 2025-06-13](https://www.keypedia.com/records/fda_inspections/shenzhen-hepalink-pharmaceutical-group-co-ltd/4479056b-15e3-42ef-845a-18902e510bfa)

Company: https://www.keypedia.com/companies/shenzhen-hepalink-pharmaceutical-group-co-ltd/b23022d9-a3c3-493b-87c3-9c00c755fdbf

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c